HUMAN METAPNEUMOVIRUS
Clinical trials for HUMAN METAPNEUMOVIRUS explained in plain language.
Never miss a new study
Get alerted when new HUMAN METAPNEUMOVIRUS trials appear
Sign up with your email to follow new studies for HUMAN METAPNEUMOVIRUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Nasal spray vaccine shows promise against childhood lung virus
⭐️ VACCINE ⭐️ CompletedThis study tested two experimental nasal spray vaccines designed to protect children against human metapneumovirus (HMPV) and parainfluenza virus type 3 (HPIV3), both of which can cause serious breathing problems. Twenty-four children aged 2 to 5 who already had antibodies to HPI…
Matched conditions: HUMAN METAPNEUMOVIRUS
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: ⭐️ VACCINE ⭐️
Last updated May 17, 2026 06:51 UTC
-
New combo vaccine targets two winter viruses in seniors
⭐️ VACCINE ⭐️ CompletedThis study tested a single-shot vaccine designed to protect against two respiratory viruses—RSV and hMPV—in adults aged 60 and older. Researchers gave different doses to 646 volunteers and checked for side effects and immune responses. A booster shot was also tested 12 months lat…
Matched conditions: HUMAN METAPNEUMOVIRUS
Phase: PHASE1, PHASE2 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: ⭐️ VACCINE ⭐️
Last updated May 15, 2026 11:57 UTC